Psychological distress and quality of life following positive fecal occult blood testing in colorectal cancer screening

被引:18
|
作者
Vermeer, Nina C. A. [1 ]
van der Valk, Maxime J. M. [1 ]
Snijders, Heleen S. [2 ]
Vasen, Hans F. A. [3 ]
van der Hoop, Arthur Gerritsen [4 ]
Guicherit, Onno R. [5 ]
Liefers, Gerrit-Jan [1 ]
van de Velde, Cornelis J. H. [1 ]
Stiggelbout, Anne M. [6 ]
Peeters, Koen C. M. J. [1 ]
机构
[1] Leiden Univ, Dept Surg, Med Ctr, POB 9600, NL-2300 RC Leiden, Netherlands
[2] Groene Hart Ziekenhuis, Dept Surg, Gouda, Netherlands
[3] Leiden Univ, Dept Gastroenterol & Hepatol, Med Ctr, Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Keizer Kliniek, The Hague, Netherlands
[5] Haaglanden Med Ctr, Dept Surg, Leidschendam, Netherlands
[6] Leiden Univ, Dept Biomed Data Sci, Med Decis Making, Med Ctr, Leiden, Netherlands
关键词
cancer; colorectal neoplasms; early detection of cancer; mass screening; oncology; psychological dysfunction; worry; EUROPEAN GUIDELINES; CONSEQUENCES; ASSURANCE; REGRET; FEAR; QUESTIONNAIRE; VALIDATION; RECURRENCE; DIAGNOSIS;
D O I
10.1002/pon.5381
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective This study aimed to assess psychological functioning, quality of life, and regret about screening after a positive fecal immunochemical test (FIT) and subsequent colonoscopy, and to evaluate changes over time. Methods This is a prospective cohort study. Individuals aged 55 to 75 with a positive FIT that were referred for colonoscopy between July 2017 and November 2018, were invited to complete questionnaires related to psychological distress and health-related quality of life at three predefined time points: before colonoscopy, after histopathology result notification, and after 6 months. Four questionnaires were used: the Psychological Consequences Questionnaire (PCQ), the six-item Cancer Worry Scale (CWS), the Decision Regret Scale (DRS), and the 36-item Short-Form (SF-36). Results A total of 1066 participants out of 2151 eligible individuals were included. Patients with cancer showed a significant increase in psychological dysfunction (P = .01) and cancer worry (P = .008) after colonoscopy result notification, and a decline to pre-colonoscopy measurements after 6 months. In the no-cancer groups, psychological dysfunction and cancer worry significantly decreased over time (P < .05) but there was no ongoing decline. After 6 months, 17% of participants with no cancer experienced high level of cancer worry (CWS >= 10). Yet, only 5% reported high level of regret about screening participation (DRS > 25). A good global quality of life was reported in participants with no cancer. Conclusion Some psychological distress remains up to 6 months after colonoscopy in participants who tested false-positive in the Dutch bowel cancer screening program.
引用
收藏
页码:1084 / 1091
页数:8
相关论文
共 50 条
  • [31] What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam, L.
    Korfage, I. J.
    Kuipers, E. J.
    Hol, L.
    van Roon, A. H. C.
    Reijerink, J. C. I. Y.
    van Ballegooijen, M.
    van Leerdam, M. E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (10) : 2321 - 2330
  • [32] Test Performance of Immunologic Fecal Occult Blood Testing and Sigmoidoscopy Compared with Primary Colonoscopy Screening for Colorectal Advanced Adenomas
    Khalid-de Bakker, Carolina A. J.
    Jonkers, Daisy M. A. E.
    Sanduleanu, Silvia
    de Bruine, Adriaan P.
    Meijer, Gerrit A.
    Janssen, Jan B. M. J.
    van Engeland, Manon
    Stockbruegger, Reinhold W.
    Masclee, Ad A. M.
    CANCER PREVENTION RESEARCH, 2011, 4 (10) : 1563 - 1571
  • [33] EFFECT OF FECAL OCCULT BLOOD TESTING ON MORTALITY FROM COLORECTAL-CANCER - A CASE-CONTROL STUDY
    SELBY, JV
    FRIEDMAN, GD
    QUESENBERRY, CP
    WEISS, NS
    ANNALS OF INTERNAL MEDICINE, 1993, 118 (01) : 1 - 6
  • [34] Potential biases in colorectal cancer screening using faecal occult blood test
    Riboe, Dea Grip
    Dogan, Tilde Steen
    Brodersen, John
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2013, 19 (02) : 311 - 316
  • [35] Time from Positive Screening Fecal Occult Blood Test to Colonoscopy and Risk of Neoplasia
    Gellad, Ziad F.
    Almirall, Daniel
    Provenzale, Dawn
    Fisher, Deborah A.
    DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (11) : 2497 - 2502
  • [36] Quantitative Immunochemical Fecal Occult Blood Testing for Colorectal Adenoma Detection: Evaluation in the Target Population of Screening and Comparison With Qualitative Tests
    Haug, Ulrike
    Hundt, Sabrina
    Brenner, Hermann
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (03): : 682 - 690
  • [37] Improvement of quality of life and psychological distress after inpatient cancer rehabilitation
    Riedl, David
    Giesinger, Johannes M.
    Wintner, Lisa M.
    Loth, Fanny L.
    Rumpold, Gerhard
    Greil, Richard
    Nickels, Alain
    Licht, Thomas
    Holzner, Bernhard
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 (19-20) : 692 - 701
  • [38] Risk stratification and detection of new colorectal neoplasms after colorectal cancer screening with faecal occult blood test: experiences from a Danish screening cohort
    Bjerrum, Andreas
    Milter, Maya Christel
    Andersen, Ole
    Fischer, Anders
    Lynge, Elsebeth
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (12) : 1433 - 1437
  • [39] Offering Annual Fecal Occult Blood Tests at Annual Flu Shot Clinics Increases Colorectal Cancer Screening Rates
    Potter, Michael B.
    Hudes, Esther S.
    McPhee, Stepben J.
    Walsh, Judith M. E.
    ANNALS OF FAMILY MEDICINE, 2009, 7 (01) : 17 - 23
  • [40] The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study
    Smith, Allan Ben
    Butow, Phyllis
    Olver, Ian
    Luckett, Tim
    Grimison, Peter
    Toner, Guy C.
    Stockler, Martin R.
    Hovey, Elizabeth
    Stubbs, John
    Turner, Sandra
    Hruby, George
    Gurney, Howard
    Alam, Mahmood
    Cox, Keith
    King, Madeleine T.
    JOURNAL OF CANCER SURVIVORSHIP, 2016, 10 (02) : 223 - 233